In trademark law, the question of whether goods or services are similar plays a pivotal role in determining if two trademarks can coexist without confusing consumers. A recent working document from the European Union Intellectual Property Office (EUIPO), dated November 2024, explores this issue in the context of pharmaceuticals and cosmetics—two categories that might seem distinct but can overlap in surprising ways. This blog post breaks down the EUIPO’s insights, offering practical guidance for trademark owners in these industries.

What Are Pharmaceuticals and Cosmetics?

To assess their similarity, we first need to define these terms under EU regulations:

• Pharmaceuticals:
  Classified under Class 5 of the Nice Classification, pharmaceuticals include substances or combinations used to treat or prevent diseases in humans or animals. Per Directive 2001/83/EC, they are defined as products with properties for treating or preventing disease, or for modifying physiological functions through pharmacological, immunological, or metabolic action.
• Cosmetics:
  Falling under Class 3, cosmetics are defined by Regulation No 1223/2009 as substances or mixtures intended for external use on the body (e.g., skin, hair, nails, lips) to clean, perfume, alter appearance, protect, maintain condition, or correct odors. Importantly, products meant to be ingested, inhaled, injected, or implanted are explicitly excluded.

While pharmaceuticals focus on medical treatment, cosmetics prioritize aesthetics and hygiene. Yet, products like cosmeceuticals—cosmetics with bioactive ingredients claiming therapeutic benefits—can blur these boundaries.

Case Law Insights: How Courts View Similarity

The EUIPO document highlights key General Court (GC) cases that illustrate how similarity is assessed:

• CLEANIC:
  The GC found that pharmaceuticals (Class 5) and cosmetics (Class 3) can share purposes, distribution channels (e.g., pharmacies), manufacturers, and target consumers. For instance, pharmaceutical preparations were deemed similar to soaps and, to a degree, cosmetics and hair care products, due to overlapping use and availability.
• PANTA RHEI:
  Referencing MITOCHRON, the GC identified a low degree of similarity between pharmaceuticals and cosmetics. While pharmaceuticals have a therapeutic purpose absent in cosmetics, both can take similar forms (e.g., creams, lotions) and target the same consumers, creating some overlap.
• SILICIUM ORGAN GANIC:
  The GC found an average degree of similarity between pharmaceuticals and specific cosmetic preparations (e.g., skin and hair care products containing organic silicon). Shared distribution channels, target audiences, and manufacturing sources supported this conclusion.

These cases show that similarity isn’t absolute—it varies by context and product specifics.

Factors Influencing Similarity

The EUIPO and courts consider several factors when evaluating similarity:

• Nature of the Goods: Pharmaceuticals are medical; cosmetics are for personal care.
• Intended Purpose: Pharmaceuticals treat or prevent disease; cosmetics enhance appearance or hygiene.
• Method of Use: Both may be applied externally (e.g., to skin), though pharmaceuticals often have stricter application rules.
• Distribution Channels: Pharmacies sell both, increasing perceived similarity.
• Target Consumers: Both appeal to the general public, with pharmaceuticals sometimes prescribed by professionals.
• Competition and Complementarity: They don’t typically compete, but cosmetics can complement pharmaceutical treatments (e.g., moisturizers alongside medicated creams).

Borderline products like cosmeceuticals add complexity, as they straddle both categories.

Practical Implications for Trademark Owners

For businesses in pharmaceuticals or cosmetics, this potential similarity has real-world implications:

• Trademark Selection: Opt for distinctive trademarks to minimize confusion with marks in either category.
• Comprehensive Searches: Search both Class 3 and Class 5 during clearance to catch potential conflicts.
• Registration Strategies: If your product could overlap (e.g., a therapeutic skincare item), consider registering in both classes.
• Monitoring and Enforcement: Track new applications in both categories to safeguard your brand.

The line between pharmaceuticals and cosmetics in trademark law isn’t always clear-cut. While their core purposes differ, shared traits like distribution channels and application methods can lead to findings of similarity—ranging from low to average, depending on the case. Trademark owners should stay proactive, tailoring their strategies to this nuanced landscape. For specific guidance, consulting a trademark professional is a smart next step.